Exane Derivatives Abb Vie Inc. Transaction History

Exane Derivatives

$157 Million
Q2 2022

A detailed history of Exane Derivatives transactions in Abb Vie Inc. stock. As of the latest transaction made, Exane Derivatives holds 1,517 shares of ABBV stock, worth $274,789. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,517

Previous 2,738 44.59%

Holding current value

$274,789

Previous $443,000 47.63%

% of portfolio

0.15%

Previous 0.14%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$137.62 - $174.96 $168,034 - $213,626	-1,221 Reduced 44.59%	1,517 $232,000
Q1 2022 Apr 22, 2022	SELL	$131.98 - $163.75 $69,553 - $86,296	-527 Reduced 16.14%	2,738 $443,000
Q4 2021 Jan 28, 2022	SELL	$107.43 - $135.93 $43,616 - $55,187	-406 Reduced 11.06%	3,265 $442,000
Q3 2021 Oct 26, 2021	BUY	$106.4 - $120.78 $3,724 - $4,227	35 Added 0.96%	3,671 $395,000
Q2 2021 Jul 28, 2021	SELL	$105.21 - $117.21 $73,857 - $82,281	-702 Reduced 16.18%	3,636 $409,000
Q1 2021 Apr 30, 2021	SELL	$102.3 - $112.62 $23,426 - $25,789	-229 Reduced 5.01%	4,338 $469,000
Q4 2020 Jan 27, 2021	SELL	$80.49 - $108.67 $509,421 - $687,772	-6,329 Reduced 58.09%	4,567 $489,000
Q3 2020 Oct 06, 2020	SELL	$85.91 - $100.83 $1.87 Million - $2.19 Million	-21,753 Reduced 66.63%	10,896 $954,000
Q2 2020 Jul 10, 2020	SELL	$73.37 - $98.18 $633,916 - $848,275	-8,640 Reduced 20.93%	32,649 $3.21 Million
Q1 2020 Apr 17, 2020	BUY	$64.5 - $97.79 $1.69 Million - $2.56 Million	26,215 Added 173.91%	41,289 $3.15 Million
Q4 2019 Jan 22, 2020	SELL	$72.13 - $90.25 $893,762 - $1.12 Million	-12,391 Reduced 45.12%	15,074 $1.33 Million
Q3 2019 Oct 15, 2019	BUY	$62.98 - $75.72 $264,327 - $317,796	4,197 Added 18.04%	27,465 $2.08 Million
Q2 2019 Jul 12, 2019	BUY	$65.7 - $83.98 $727,167 - $929,490	11,068 Added 90.72%	23,268 $0
Q1 2019 Apr 24, 2019	SELL	$77.14 - $90.79 $2.79 Million - $3.28 Million	-36,125 Reduced 74.75%	12,200 $0
Q4 2018 Jan 31, 2019	BUY	$77.85 - $96.01 $3.07 Million - $3.78 Million	39,395 Added 441.15%	48,325 $4.46 Million
Q3 2018 Oct 24, 2018	SELL	$88.91 - $98.84 $243,257 - $270,426	-2,736 Reduced 23.45%	8,930 $0
Q2 2018 Jul 19, 2018	SELL	$89.78 - $106.23 $1.77 Million - $2.09 Million	-19,688 Reduced 62.79%	11,666 $0
Q1 2018 Apr 30, 2018	BUY	$92.01 - $123.21 $485,904 - $650,672	5,281 Added 20.25%	31,354 $0
Q4 2017 Jan 29, 2018	SELL	$89.56 - $98.21 $423,260 - $464,140	-4,726 Reduced 15.34%	26,073 $0
Q3 2017 Oct 18, 2017	BUY	$69.85 - $89.22 $2.15 Million - $2.75 Million	30,799	30,799 $0

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Account

Exane Derivatives Abb Vie Inc. Transaction History